Agios Pharmaceuticals | AGIO - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 -1.47 -1.78 Oct/29
FY2026Q2 Jun/2026 -1.69 -1.67 -1.93 Jul/30
FY2026Q1 Mar/2026 -1.69 -1.79 -1.55 Apr/29
FY2025Q4 Dec/2025 -1.86 -1.95 -1.44 Feb/12
FY2025Q3 Sep/2025 -1.78 -1.91 16.22 Oct/30




Eps Alterar Data
AbbVie USD 3.65 1 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
Arrowhead Research USD -1.36 0.43 2026-06
Astellas Pharma JPY 79.15 54.86 2026-06
AstraZeneca USD 2.63 0.05 2026-06
Bayer EUR 0.95 1.76 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Daiichi Sankyo JPY 37.72 11.03 2026-06
Eli Lilly USD 8.38 0.17 2026-06
Exelixis USD 0.91 0.04 2026-06
Gilead Sciences USD -6.75 8.78 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Merck USD -0.13 1.15 2026-06
Moderna USD -1.97 1.43 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Novartis USD 2.41 0.42 2026-06
Novartis USD 1.99 0.45 2026-03
Pfizer USD 0.77 0.02 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Roche Holding CHF 10.98 2.61 2026-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06